Læknablaðið - 15.09.1983, Qupperneq 42

216
LÆK.NABLADID
4) Nataf R, Lépine P, et Bonamour G. Oeil et virus.
Masson et Cie Paris 1960.
5) Ragnar Sigurðsson augnlæknir. Persónulegar
upplýsingar 1982.
6) Norn MS. Dendritic (Herpetic) Keratitis I. Acta
Ophthalmol 1970;48:91-107.
7) Ribaric V. The Incidence of Herpetic Keratitis
among Popultation. Ophthalmologica 1976; 173;
19-22.
8) Kamp Mortensen K, Sjolie AK. Keratitis Dend-
ritica. An epidemiological investigation. Acta
Ophthalmol 1979; 57: 750-4.
9) Gundersen T. Herpes Cornea with Special
Reference to its Treatment with Strong Soluti-
on of Iodine. Arch Ophthalmol 15 (new series):
1936;225-49.
10) Jonkers GH. Statistical Investigation on the
Occurrence of Herpes Simplex Cornea. Oph-
thalmologica 1962; 144:405-8.
11) Kvapilíková K. Incidence of Herpetic Keratitis
and New Possibilities of its Treatment Cs.
Oftalmol 1966; 22(2): 113-7.
12) Otsachapowski und Lipowskaja. Pathologis-
chen physioiogie der Hornhaut. Herpetische
keratitis. Soviet Westn Oftalmol 1934; 5: 109.
13) Peterhans A, Statistische betractungen an 426 in
der Basler Augenklinik behandelten Fállen von
Herpes Cornea. Ophthalmologica 1955; 130:
244-71.
14) Vancea PP, Calin A, Colev G, Popescu V.
Studiul Clinicostatistic al cazurilor de keratita
herpetica internate in Clinica de oftalmologie
Iasi in perioada 1970-1974. Revista de: Chirur-
gie, Oncologie, Radiologie, Oftalmologie, Sto-
matologie. Oftalmologia 1977; 21(2): 111-4.
15) Zamorani G. Osservazioni statistiche sui ricove-
ri per cheratite erpetica nella Clinica Oculistica
di Ferrara dal 1959 al 1964. L’ Arcispedale S.
Anna di Ferrara 1967; 20: 87-96.
16) Leopold 1H, Sery TW. Epidemiology of herpes
simplex keratitis. invest Ophthalmol 1963; 2:
498-503.
17) Gold JA, Stewart RC, McKee J. The Epidemio-
logy and Chemotherapy of Herpes Simplex
Keratitis and Herpes Simplex Skin Infections.
Ann NY Acad Sci 1965; 130: 209-12.
18) Schenk H, Hummer E. Statistische Untersu-
chungen herpetischer Hornhauterkrankungen
aus 3 Dekaden der Jahre 1926-1955. v. Graefes
Arch fur Ophthalmol 1958; 160: 368-77.
19) Pietruschka G. Zur Epidemiologie und Therapie
des Herpes Cornea. Das Deutsche Gesundheits-
wesen 1968; 23: 1249-54.
20) Sood NN, Marmion VJ. Superficial Herpetic
Keratitis treated with 5-iodo-2-deoxyuridine.
Brit J Ophthalmol 1964; 48: 609-14.
21) Thygeson P, Kimura SJ, Hogan MJ. Observati-
ons on Herpetic Keratitis and Keratoconjuncti-
vitis. Arch Ophthalmoi 1956; 56: 375-88.
22) Burnet FM, Lush D. Herpes simplex. Studies on
the antibody content of human sera. The Lancet
1939; 1:629-31.
23) Duke-Elder Sir Stewart. System of Ophthaimol,
VIII, part II, bls. 313. London Henry Kimpton
1965.
24) Caroleo D. Epidemiologia della cheratite erpe-
tica. Ann di Ottalmol et Clin Ocul, 1970; 96: 59-
64.
25) Shuster JJ, Kaufman HE, Nesburn AB. Analysis
of the Rate of Recurrence of Herpesvirus
Ocular Epithelial Disease. Am j Ophthalmol
1981;91:328-31.
26) Marré M. Vorkommen und Verlauf enziindli-
cher Hornhauterkrankungen in verschiedenen
Lebensaltern. Zeitschrift fiir Alternsforsch 1968;
21: 137-46.
27) Jones BR. Rational regimen of administration of
antivirals. Trans Am Acad Ophthalmol Otola-
ryngol 1975; 79: 104-8.
28) Björn Önundarson tryggingayfirlæknir. Per-
sónulegar upplýsingar 1979.
29) Pavan-Langston D, Hettinger ME. Ocular Her-
pes: An Update. Ann Ophthalmol 1981; 13(10):
1213-6.